There are 3161 resources available
224P - Lung cancer scRNA-seq analyses reveal potential mechanisms causing different efficacy of target therapy and immunotherapy between EGFR 19del and L858R lung adenocarcinoma
Presenter: Hao Wang
Session: Poster session 09
225P - Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M)
Presenter: Junko Tanizaki
Session: Poster session 09
226TiP - CLEAR-Me: Interception trial to detect and clear molecular residual disease in patients with high-risk melanoma
Presenter: Erick Saldanha
Session: Poster session 09
227TiP - A phase II, open label, randomized, non-comparative cohorts study of adjuvant atezolizumab or atezolizumab plus tiragolumab in solid tumors with resectable disease with intermediate-high risk of recurrence and high tumor mutational burden (TMB-H) or microsatellite instability (MSI-H)
Presenter: Guillermo Antonio De Velasco Oria
Session: Poster session 09
228TiP - FINPROVE: The Finnish national study to facilitate patient access to targeted anti-cancer drugs
Presenter: Mika Mustonen
Session: Poster session 09
229TiP - A phase II trial of a neural network-based treatment decision support tool in patients (pts) with refractory solid organ malignancies
Presenter: Robert Walsh
Session: Poster session 09
230TiP - Exploring mechanisms of action and resistance in innovate cancer therapies: The UNLOCK program
Presenter: Beatriz Alonso de Castro
Session: Poster session 09
694P - Sequential high-dose-chemotherapy with 4 cycles paclitaxel, ifosfamide, carboplatin, etoposide (P-ICE) in relapsed/refractory male germ cell cancer: Final results with 15.8 years follow-up
Presenter: Hans Joachim Schmoll
Session: Poster session 09
695P - Assessment of the utility of CT scans in the long-term follow-up of metastatic non-seminomatous germ cell tumours (mNSGCT): The Late CT study
Presenter: Deep Chakrabarti
Session: Poster session 09